...
首页> 外文期刊>Scandinavian journal of infectious diseases. >Aspergillus sp isolated in critically ill patients with extracorporeal membrane oxygenation support
【24h】

Aspergillus sp isolated in critically ill patients with extracorporeal membrane oxygenation support

机译:重症患者体外膜氧合支持下分离的曲霉菌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study reports Aspergillus isolation in critically ill patients who underwent extracorporeal membrane oxygenation (ECMO) and highlights the difficulty in establishing a diagnosis of aspergillosis in this population. The diagnosis of Aspergillus infection or colonization was retrospectively performed using the proposed modified criteria of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group (EORTC/MSG) adapted to critically ill patients. Between 2005 and 2011, 11 of 151 patients (7.2%) who underwent ECMO had Aspergillus sp. isolates, 10 in a pulmonary sample and 1 in a mediastinal wound sample. Five patients did not have any classical risk factors for aspergillosis. One patient had a proven invasive pulmonary aspergillosis (IPA), 2 had a putative IPA, and 1 patient had a possible Aspergillus mediastinitis, whilst in 7 patients this was considered colonization. However, the clinical relevance of Aspergillus isolation was based on an algorithm not validated in patients undergoing ECMO. Our data support the need to implement non-invasive diagnostic procedures for aspergillosis in this population.
机译:这项研究报告了接受体外膜氧合(ECMO)的危重患者中曲霉菌的分离,并强调了在该人群中诊断曲霉病的难度。使用欧洲癌症研究与治疗组织和适用于重症患者的真菌病研究组(EORTC / MSG)的拟议修改标准,回顾性地进行了曲霉菌感染或定植的诊断。在2005年至2011年之间,接受ECMO的151名患者中有11名(7.2%)患有曲霉菌。在肺部样本中有10例在纵隔伤口样本中有1例。五名患者没有曲霉病的任何经典危险因素。一名患者被证实具有侵袭性肺曲霉病(IPA),两名患者被假定为IPA,另一名患者可能患有纵隔曲霉菌纵隔炎,而在七名患者中这被认为是定植。但是,曲霉菌分离的临床相关性基于未经ECMO验证的算法。我们的数据支持对该人群曲霉病实施非侵入性诊断程序的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号